Considering that the mechanisms about the ASIC3 and P2X3 studied in the human PAD patients are currently lacking, the investigations on these receptors in regulating the exercise pressor reflex in an animal model, as well as the interaction among the molecular components are anticipated to provide basic evidence for the pharmacological intervention used for the clinical treatment and management of PAD. This evidence concerns the gene ASIC3 and peripheral arterial disease.